Bryan Roberts Biography

With biotech booming life sciences specialist Bryan Roberts has been on a streak with exits in Castlight Health (IPO 2014) Receptos (IPO 2013) Zeltiq Aethetics (IPO 2011) and Ironwood Pharmaceuticals (IPO 2010). Castlight which helps companies lower their health care costs was incubated by Roberts (he is chairman) and went out with a $1.4 billion market cap on $13 million in revenue. Another of his companies non-invasive prenatal testing company Ariosa Diagnostics was acquired in Dec. 2014 by Roche. Current portfolio faves include Doctor on Demand and Achaogen (antibiotics for drug-resistant infections). Roberts does an annual three-day mountain trail run dubbed the Death March. And you thought venture capital was tough. Roberts cut his teeth as a banker at Kidder Peabody & Co. before earning a Ph.D. in chemistry and chemical biology at Harvard.
Contact a speaker booking agent to check availability on Bryan Roberts and other top speakers and celebrities.

As a renowned expert and highly sought-after speaker, Bryan Roberts's expertise is in high demand. To book Bryan Roberts for your next event, conference, or workshop, please contact our speaker booking agency. Our experienced team will work closely with you to understand your specific needs and help secure Bryan Roberts's participation. With our professional guidance and seamless booking process, you can ensure a memorable and impactful experience for your audience. Don't miss the opportunity to engage your audience with Bryan Roberts's compelling insights and inspire positive change within your organization. Fill out the booking request form to take the first step in securing Bryan Roberts for your next speaking engagement.